Search reports.
Creatinine Measurement Market Share & Growth | Forecast 2030
Get free sample report Request for Customiztion Buy Now

Creatinine Measurement Market Share & Growth | Forecast 2030

Segments - Creatinine Measurement Market by Types (Jaffe’s Kinetic Method and Enzymatic Method), Types of Sample (Blood/Serum and Urine), End-users (Hospitals, Diagnostic Laboratories, and Others), Products (Reagents, and Kits), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-1244 | 4.7 Rating | 66 Reviews | 186 Pages | Format : PDF Excel PPT

Report Description


The global creatinine measurement market size is anticipated to expand at a significant CAGR during the forecast period, 2021 – 2028. The growth of the market is attributed to the high pervasiveness of renal disorders.
 

Creatinine Measurement Market Key Takeaways


Creatinine is a naturally occurring byproduct of muscle metabolism. The clinical laboratory calculation of this waste product is used to determine glomerular filtration rate (GFR), which further determines patients' kidney activity. Jaffe's kinetic methods and enzymatic methods are two popular techniques used in the majority of routine creatinine assays currently in use. Creatinine measurement is primarily related to the identification and examination of rigorous renal disorders, which is mostly conducted using blood sample or urine sample of patients.

According to a data published by the American Kidney Fund, kidney diseases is the ninth leading cause of death in the US and chronic kidney disease gas affected more than 31 million people in the country alone. The presence of kidney disorders can be responsible for occurrence of several other chronic illness to a patient such as decreasing glomerular filtration rate has been linked to cardiovascular disease. One of the key aspects for the market expansion is the rapid growth of various technological advancement such as the introduction for the use of point-of-care creatinine measurement devices as a quick tool. The development has contributed to the elimination of the need for professional scientific professionals to carry out complex testing techniques.

Market Trends, Drivers, Restraints, and Opportunities

  • High prevalence of rigorous renal disorders and rising cases of renal-related diseases are key drivers for the growing demand for creatinine measurement process. This is expected to boost the market.
  • Growing development of health institutions as well as several government initiatives for the establishment of diagnostic clinics and hospitals are expected to propel the market expansion.
  • Rapid development and production of innovative creatinine measurement kits and reagents from players to enhance the measurement techniques and methods are driving the market growth.
  • Increasing number of the global geriatric population, who are more susceptible to renal diseases and favorable government policies to improve renal-based wellbeing present another key factors pushing the market.
  • Changing healthcare professional tastes for novel approaches such as the detection of renal disease biomarkers and the lack of predictive utility achieved by creatinine calculation techniques, are key challenges likely to restrict the market expansion.

Scope of the Report

The report on the global creatinine measurement market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Creatinine Measurement Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2020

Historic Data

2018–2019

Forecast Period

2021–2028

Segmentation

Types (Jaffe’s Kinetic Method and Enzymatic Method), Types of Sample (Blood/Serum and Urine), End-users (Hospitals, Diagnostic Laboratories, and Others), and Products (Reagents, and Kits)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

BioAssay Systems, Abcam plc, Arbor Assays, Thermo Fisher Scientific, Randox Laboratories Ltd., Sentinel CH. SpA, DiaSys Diagnostic Systems GmbH, MedTest Holdings, Inc. (Pointe Scientific, Inc.), Abbexa Ltd., and General Atomics, Inc. (Diazyme Laboratories, Inc.).

 

Market Segment Insights

Jaffe’s Kinetic Method segment to constitute a substantial share
On the basis of types, the global creatinine measurement market is bifurcated into Jaffe’s kinetic method and enzymatic method. The Jaffe’s kinetic method segment is expected to constitute a substantial market share in the coming years owing to the wide deployment of the method for the measurement procedures.

Blood Sample segment to hold a large market share
Based on types of sample, the market is bifurcated into blood/serum and urine. The blood segment is anticipated to account for a large share of the creatinine measurement market during the forecast period due to its improved precision and low chance of infection. Moreover, the rising adoption of the sample as the most favored process for reliable creatinine calculation is another key aspect for the segment growth.

Hospitals segment to accounts for a major share
Based on the end-users, the creatinine calculation market is divided into hospitals, diagnostic laboratories, and others. The hospitals segment is projected to accounts for a key share of the market because of existing infrastructures with advanced diagnostic assemblies for improved diagnostic outcomes in shorter time periods. However, the diagnostic laboratories segment is anticipate to expand at a substantial CAGR during the forecast period owing to easy accessibility and rapid expansion of various private diagnostic clinics.
 

Creatinine Measurement Market by End Users


Kits segment is to exhibit a high CAGR
On the basis of products, the market is segregated into reagents and kits. The kits segment is projected to exhibit a considerable CAGR during the forecast period owing to rapid production of advanced and high-accurate measurement devices. Rising development of innovative technology and techniques for the deployment of kits is another key driving factor for the segment growth.

Asia Pacific market is expected to grow at a rapid pace
In terms of regions, the global creatinine measurement market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market in Asia Pacific is anticipated to grow at a rapid pace during the forecast period due to factors such as increasing CKD prevalence, increased understanding of preventive healthcare, improved healthcare facilities, and a growing focus of market players on meeting demand in many Asian countries. Furthermore, as the existing markets become saturated, Asia is projected to become a key market destination for creatinine package and reagent providers in the coming years.
 

Creatinine Measurement Market by Regions

Segments

Segments Covered in the Report
The global creatinine measurement market has been segmented on the basis of

Types

  • Jaffe’s kinetic method
  • Enzymatic method

Types of Sample

  • Blood/serum
  • Urine

End-users

  • Hospitals
  • Diagnostic Laboratories
  • Others

Products

  • Reagents
  • Kits

Regions

  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa

Key Players

  • BioAssay Systems
  • Abcam plc
  • Arbor Assays
  • Thermo Fisher Scientific
  • Randox Laboratories Ltd.
  • Sentinel CH. SpA
  • DiaSys Diagnostic Systems GmbH
  • MedTest Holdings, Inc.

Competitive Landscape

Some of the key players of the global creatinine measurement market are BioAssay Systems, Abcam plc, Arbor Assays, Thermo Fisher Scientific, Randox Laboratories Ltd., Sentinel CH. SpA, DiaSys Diagnostic Systems GmbH, and MedTest Holdings, Inc. These industry players are actively enagaged in developing advanced kits and reagents, as well as introducing innovative strategies for increasing their market positions.
 

Creatinine Measurement Market by key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Creatinine Measurement Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Creatinine Measurement Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Creatinine Measurement Market - Supply Chain
  4.5. Global Creatinine Measurement Market Forecast
     4.5.1. Creatinine Measurement Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Creatinine Measurement Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Creatinine Measurement Market Absolute $ Opportunity
5. Global Creatinine Measurement Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Creatinine Measurement Market Size and Volume Forecast by Types
     5.3.1. Jaffe’s kinetic method
     5.3.2. Enzymatic method
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Creatinine Measurement Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Creatinine Measurement Market Size and Volume Forecast by End Users
     6.3.1. Hospitals
     6.3.2. Diagnostic Laboratories
     6.3.3. Others
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Creatinine Measurement Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Creatinine Measurement Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Creatinine Measurement Demand Share Forecast, 2019-2026
8. North America Creatinine Measurement Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Creatinine Measurement Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Creatinine Measurement Market Size and Volume Forecast by Types
     8.4.1. Jaffe’s kinetic method
     8.4.2. Enzymatic method
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Creatinine Measurement Market Size and Volume Forecast by End Users
     8.7.1. Hospitals
     8.7.2. Diagnostic Laboratories
     8.7.3. Others
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Creatinine Measurement Demand Share Forecast, 2019-2026
9. Latin America Creatinine Measurement Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Creatinine Measurement Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Creatinine Measurement Market Size and Volume Forecast by Types
     9.4.1. Jaffe’s kinetic method
     9.4.2. Enzymatic method
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Creatinine Measurement Market Size and Volume Forecast by End Users
     9.7.1. Hospitals
     9.7.2. Diagnostic Laboratories
     9.7.3. Others
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Creatinine Measurement Demand Share Forecast, 2019-2026
10. Europe Creatinine Measurement Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Creatinine Measurement Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Creatinine Measurement Market Size and Volume Forecast by Types
     10.4.1. Jaffe’s kinetic method
     10.4.2. Enzymatic method
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Creatinine Measurement Market Size and Volume Forecast by End Users
     10.7.1. Hospitals
     10.7.2. Diagnostic Laboratories
     10.7.3. Others
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Creatinine Measurement Demand Share Forecast, 2019-2026
11. Asia Pacific Creatinine Measurement Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Creatinine Measurement Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Creatinine Measurement Market Size and Volume Forecast by Types
     11.4.1. Jaffe’s kinetic method
     11.4.2. Enzymatic method
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Creatinine Measurement Market Size and Volume Forecast by End Users
     11.7.1. Hospitals
     11.7.2. Diagnostic Laboratories
     11.7.3. Others
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Creatinine Measurement Demand Share Forecast, 2019-2026
12. Middle East & Africa Creatinine Measurement Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Creatinine Measurement Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Creatinine Measurement Market Size and Volume Forecast by Types
     12.4.1. Jaffe’s kinetic method
     12.4.2. Enzymatic method
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Creatinine Measurement Market Size and Volume Forecast by End Users
     12.7.1. Hospitals
     12.7.2. Diagnostic Laboratories
     12.7.3. Others
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Creatinine Measurement Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Creatinine Measurement Market: Market Share Analysis
  13.2. Creatinine Measurement Distributors and Customers
  13.3. Creatinine Measurement Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. BioAssay Systems
     13.4.2. Abcam plc
     13.4.3. Arbor Assays
     13.4.4. Thermo Fisher Scientific
     13.4.5. Randox Laboratories Ltd.
     13.4.6. Sentinel CH. SpA
     13.4.7. DiaSys Diagnostic Systems GmbH
     13.4.8. MedTest Holdings, Inc.

Methodology

Our Clients

Siemens Healthcare
Deloitte
Dassault Aviation
The John Holland Group
General Electric
Pfizer
General Mills
Microsoft